Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact
about
G-protein-coupled receptors signaling pathways in new antiplatelet drug developmentRespiratory epithelial cells orchestrate pulmonary innate immunity.Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic CancerEvolution of the protease-activated receptor family in vertebratesDifferential signaling by protease-activated receptors: implications for therapeutic targeting.A highly potent agonist to protease-activated receptor-2 reveals apical activation of the airway epithelium resulting in Ca2+-regulated ion conductanceCardiovascular impact of drugs used in the treatment of diabetesThrombin Activates Latent TGFβ1 via Integrin αvβ1 in Gingival Fibroblasts.Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation.Modulation of protease-activated receptor expression by Porphyromonas gingivalis in human gingival epithelial cells.Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER StatusFunctional diversity of secreted cestode Kunitz proteins: Inhibition of serine peptidases and blockade of cation channels.Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.Contributions of protein kinases and β-arrestin to termination of protease-activated receptor 2 signaling.The emerging role of coagulation proteases in kidney disease.Teleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells.The characteristics of thrombin in osteoarthritic pathogenesis and treatment.Diverse functions of defensins and other antimicrobial peptides in periodontal tissues.Vorapaxar in the secondary prevention of atherothrombosis.Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect of LMWH tinzaparin.Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.Coagulation and non-coagulation effects of thrombin.Proteinases, Their Extracellular Targets, and Inflammatory Signaling.Innate immunity, hemostasis and matrix remodeling: PTX3 as a link.Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.Targeting PAR1: Now What?Homeostatic effects of coagulation protease-dependent signaling and protease activated receptors.Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.Allergen-dependent oxidant formation requires purinoceptor activation of ADAM 10 and prothrombin.Protease-Activated Receptor 2 Promotes Pro-Atherogenic Effects through Transactivation of the VEGF Receptor 2 in Human Vascular Smooth Muscle Cells.Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception.Microglia Activation and Polarization After Intracerebral Hemorrhage in Mice: the Role of Protease-Activated Receptor-1.The Interactive Roles of Lipopolysaccharides and dsRNA/Viruses on Respiratory Epithelial Cells and Dendritic Cells in Allergic Respiratory Disorders: The Hygiene Hypothesis.Identification of the minimum PAR4 inhibitor pharmacophore and optimization of a series of 2-methoxy-6-arylimidazo[2,1-b][1,3,4]thiadiazoles.Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections.Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma.Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.
P2860
Q26864951-49A44F43-DFAE-4F11-A49B-841320C89795Q27687743-9EC64A0B-DC04-465C-B7BE-5CAEE516D38FQ28079318-594135A7-81C7-4DF4-884A-530605138670Q28603611-68E8976E-A249-44B4-B19E-034C1BE0C732Q33580620-6C191718-2931-4BB4-9491-3F45C0DAC140Q34353956-8A58D866-3E8A-4A2C-8716-06EB5FF28552Q34383575-55FE868C-A75E-4BC9-8B21-889DF77F3651Q34675875-BD39E725-082E-4960-9A1E-446605558E59Q35396873-8C0392A7-864A-46A1-9DD1-2F0F8012A4A7Q35811480-BB0D01CA-849F-4085-9E5C-A1657523C754Q35921287-C0947452-D2AE-4DFF-AABB-38CC16F82BF5Q36278814-C141E83D-CA5F-4954-8DF3-52A0354F95DAQ36283713-66691844-5E7B-4CFB-A5FC-B0D2D399C1ADQ36322931-D285C3B6-2696-4093-BD5F-9A28EC6E907EQ36634318-F831CA47-38B2-4F20-AE9E-887A433A9A42Q37066587-E1417DED-2E4F-4B55-9B66-E9CFDF33FB96Q37591794-F6341B15-D45E-407A-9297-F5CA49F4DE47Q38260033-19C48057-2301-4F6C-B6AB-AFA4517A9BADQ38562428-2E0CC34B-902D-4622-894D-69F87A96ED3DQ38630968-58CE85CB-01DC-4034-845F-7C98C4D5606AQ38756901-9940A430-B52A-4381-9236-BA0E7082747CQ38830839-95F836D8-4D40-4933-B63D-DF3942240E03Q38924721-7D7D4752-99A2-49C5-860E-476C6A1DCAA7Q38966192-30162291-BBBF-4EB6-A68A-89268F8F9E8AQ39018377-36964C97-6C9D-4007-A638-178D787E4BBFQ39113924-C8BF9FC7-7593-4FE2-9B03-50051F957C5CQ39338913-AE09A366-2A39-46C2-BA7D-E49F3DF983F3Q39410950-C4CB5A21-34FC-4BF4-9863-1C1FE16C1ED9Q39540197-829D3220-2048-45ED-B9EA-8AED24BBA424Q40263863-CC7D474B-4AA7-413F-9875-D040542D5FACQ40362480-00E37712-402F-45CD-87AC-2AEACEB23187Q40630385-16363EA0-5DB6-45D8-AE21-05B0898E820DQ41635414-1DC648D5-3B7A-4BE4-8654-554E6FD937AEQ42339322-743E6A06-8E84-459F-8D79-69CBBBAA2F27Q42493460-BF1796CF-9BDF-41C4-8C0E-3CB216256E48Q43042897-12E793E3-3038-41FC-8BC5-86FCC74E15E9Q43675220-AB628A7F-35D8-464F-97F1-06652A4760F8Q45325250-8248F63E-980F-49E3-AA3A-2731F68741DAQ46588142-22103C28-A6BC-47AE-894B-2FB0BE7BBE05Q47118943-AA51E40F-3AF9-4B15-BACF-29B6297950B7
P2860
Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Proteinase-activated receptors ...... and pathophysiological impact
@en
type
label
Proteinase-activated receptors ...... and pathophysiological impact
@en
prefLabel
Proteinase-activated receptors ...... and pathophysiological impact
@en
P2093
P2860
P921
P356
P1476
Proteinase-activated receptors ...... and pathophysiological impact
@en
P2093
Hendrik Ungefroren
Morley D Hollenberg
Roland Kaufmann
Utz Settmacher
P2860
P2888
P356
10.1186/1478-811X-11-86
P577
2013-11-11T00:00:00Z
P6179
1022488951